FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only.
MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 15, 2021.
Vinca alkaloid misadministration is a persistent problem that results in patient harm and death. This alert raises awareness of label changes that aim to mitigate accidental spinal administration of the high-alert chemotherapy agent by supporting infusion bag administration only.